AK9
protein-codingadenylate kinase 9, the group of Adenylate kinases
Gene summary
The protein encoded by this gene catalyzes the interconversion of nucleosides, possessing both nucleoside monophosphate and diphosphate kinase activities. The encoded protein uses these interconversions to maintain nucleoside homeostasis. [provided by RefSeq, Jul 2016]
- C6orf224
- AKD2
- C6orf199
- AKD1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~198.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
Clinical Genomic Database (CGD)
Manifestation: Genitourinary
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AK9 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001145128.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 3 | 6 | 10 | ||
| missense | 1 | 1 | 191 | 11 | 3 | 207 |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 4 | 6 | |||
| Total | 3 | 3 | 196 | 14 | 9 | 225 |
Highest pathogenic variant AF is 0.0002748504
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001138600.2 | 40 | MANE Select | |
| Ensembl | ENSP00000410186.2 | 40 | MANE Select | |
| RefSeq | NP_001316531.1 | 11 | Standard | |
| RefSeq | NP_001316532.1 | 12 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ak9 | Danio rerio | Structure: otolith Quality: morphology abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Pyrimidine metabolism - Homo sapiens (human)
- Purine metabolism - Homo sapiens (human)
- Metabolism of nucleotides
- Interconversion of nucleotide di- and triphosphates
- Metabolism
Biological Process
- dADP phosphorylation
- dGDP phosphorylation
- AMP phosphorylation
- ATP generation from ADP
- nucleobase-containing small molecule interconversion
Molecular Function
- nucleoside diphosphate kinase activity
- ATP binding
- nucleoside kinase activity
- nucleoside monophosphate kinase activity
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- cytosol
- nuclear membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000424296
- Coding exons
- 40
- Length
- 198362
- Individuals with no LoFs
- 125607
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 141
- Defined
- 125748
- p
- 0.000561
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.19 | 725 | 911 | 0.795 | 0.0000445 | 12605 |
| Missense (PolyPhen) | 259 | 308.46 | 0.83965 | 4256 | ||
| Synonymous | 2.34 | 254 | 306 | 0.830 | 0.0000152 | 3325 |
| Loss of Function | 3.71 | 57 | 96.3 | 0.592 | 0.00000453 | 1418 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.0012 | 0.00098 | notable |
| Ashkenazi Jewish | 0.0013 | 0.0013 | notable |
| East Asian | 0.00028 | 0.00027 | rare |
| Finnish | 0.00024 | 0.00023 | rare |
| European (Non-Finnish) | 0.00050 | 0.00049 | rare |
| South Asian | 0.00067 | 0.00062 | rare |
| Other | 0.0010 | 0.00098 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in maintaining the homeostasis of cellular nucleotides by catalyzing the interconversion of nucleoside phosphates. Has both nucleoside monophosphate and diphosphate kinase activities. Catalyzes the phosphorylation of AMP, dAMP, CMP and dCMP with ATP as phosphate donor and of CMP with GTP as phosphate donor. Also catalyzes the production of ATP, CTP, GTP, UTP, dATP, dCTP, dGTP and TTP from the corresponding diphosphate substrates with either ATP or GTP as phosphate donor. Shows substrate preference of CDP > UDP > ADP > GDP > TDP. {ECO:0000269|PubMed:23416111}.;
Recessive Scores
- pRec
- 0.0711
Intolerance Scores
- RVIS EVS
- 1.72
- RVIS percentile EVS
- 96.5
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |